Follicular Lymphoma

Common Name(s)

Follicular Lymphoma

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Follicular Lymphoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Follicular Lymphoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Follicular Lymphoma" returned 700 free, full-text research articles on human participants. First 3 results:

A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up.
 

Author(s): Alessia Bari, Raffaella Marcheselli, Luigi Marcheselli, Isabel Alvarez, Samantha Pozzi, Paola Ferri, Antonio Lazzaro, Alberto Fragasso, Santo Neri, Luca Baldini, Angelo Michele Carella, Francesco Angrilli, Roberto Guariglia, Gabriele Buda, Caterina Stelitano, Stefano Sacchi,

Journal: Acta Haematol.. 2017 ;137(1):7-14.

 

Single-agent bortezomib (B) has shown activity in heavily pretreated patients with relapsed/refractory indolent lymphoma. On the basis of these findings, we performed a phase II study of B combined with rituximab (R) in patients with relapsed follicular lymphoma (FL). Forty-five patients ...

Last Updated: 7 Nov 2016

Go To URL
Influence of the watch and wait strategy on clinical outcomes of patients with follicular lymphoma in the rituximab era.
 

Author(s): Sayako Yuda, Dai Maruyama, Akiko Miyagi Maeshima, Shinichi Makita, Hideaki Kitahara, Ken-Ichi Miyamoto, Suguru Fukuhara, Wataru Munakata, Tatsuya Suzuki, Yukio Kobayashi, Kinuko Tajima, Hirokazu Taniguchi, Kensei Tobinai

Journal: Ann. Hematol.. 2016 Dec;95(12):2017-2022.

 

We analyzed the effects of the initial approach to patients with follicular lymphoma (FL) on outcomes in order to investigate whether the watch and wait (WW) strategy is still an acceptable approach in the rituximab era. We retrospectively analyzed 348 patients who were initially ...

Last Updated: 26 Sep 2016

Go To URL
Remission of Follicular Lymphoma after Treatment for Hepatitis C Virus Infection.
 

Author(s): Nicola Maciocia, Alastair O'Brien, Kirit Ardeshna

Journal: N. Engl. J. Med.. 2016 Oct;375(17):1699-1701.

 

Last Updated: 26 Oct 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Follicular Lymphoma" returned 77 free, full-text review articles on human participants. First 3 results:

Follicular Lymphoma: The Role of the Tumor Microenvironment in Prognosis.
 

Author(s): Takumi Sugimoto, Takashi Watanabe

Journal: J Clin Exp Hematop. 2016 ;56(1):1-19.

 

The microenvironment of follicular lymphoma (FL) is composed of tumor-infiltrating CD8(+) T cells, follicular regulatory T cells, lymphoma-associated macrophages and mast cells, follicular helper T cells, follicular dendritic cells, and follicular reticular cells, all of which have ...

Last Updated: 23 Jun 2016

Go To URL
Diagnosis of follicular lymphoma of the gastrointestinal tract: A better initial diagnostic workup.
 

Author(s): Masaya Iwamuro, Eisei Kondo, Katsuyoshi Takata, Tadashi Yoshino, Hiroyuki Okada

Journal: World J. Gastroenterol.. 2016 Jan;22(4):1674-83.

 

Due to an increasing incidence and more frequent recognition by endoscopists, gastrointestinal follicular lymphoma has been established as a variant of follicular lymphoma. However, due to its rarity, there are no established guidelines on the optimal diagnostic strategy for patients ...

Last Updated: 28 Jan 2016

Go To URL
Colorectal Manifestation of Follicular Lymphoma.
 

Author(s): Masaya Iwamuro, Hiroyuki Okada, Katsuyoshi Takata, Ryuta Takenaka, Tomoki Inaba, Motowo Mizuno, Haruhiko Kobashi, Shouichi Tanaka, Masao Yoshioka, Eisei Kondo, Tadashi Yoshino, Kazuhide Yamamoto

Journal: Intern. Med.. 2016 ;55(1):1-8.

 

Due to their rarity, the endoscopic features and clinical backgrounds of colorectal follicular lymphoma lesions have not yet been fully investigated. The aim of this study was to reveal the characteristics of this disease entity.

Last Updated: 4 Jan 2016

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Rituximab With or Without Ibrutinib for Patients With Advanced Follicular Lymphoma
 

Status: Recruiting

Condition Summary: Follicular Lymphoma

 

Last Updated: 24 Feb 2017

Go to URL